Redmond Asset Management, LLC Chembio Diagnostics, Inc. Transaction History

Redmond Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 10, 2020	SELL	$3.18 - $15.54 $84,028 - $410,628	-26,424 Closed	0 $0
Q1 2020 May 06, 2020	BUY	$2.36 - $5.6 $2,360 - $5,600	1,000 Added 3.93%	26,424 $135,000
Q4 2019 Feb 11, 2020	BUY	$3.94 - $5.76 $788 - $1,152	200 Added 0.79%	25,424 $115,000
Q3 2019 Nov 07, 2019	BUY	$4.84 - $7.25 $122,084 - $182,874	25,224 New	25,224 $154,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Redmond Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Redmond Asset Management, LLC with notifications on news.